Sera Prognostics has appointed Nadia Altomare as chief commercial officer. In this role, she will lead all commercial activities for Sera as the company makes its groundbreaking PreTRM test available to physicians and patients. Altomare has held senior management positions in single and multi-product/service environments spanning from entrepreneurial to Fortune 500 companies. She joins Sera Prognostics from Abcondia where she served as CEO. Prior to that, she served as VP and general manager of the DNA analysis business at Thermo Fisher Scientific, formerly Life Technologies. She has also held leadership roles at PerkinElmer, including the VP and general manager of the cytogenetic DNA testing business and BP of commercial operations.